RANI
Price
$0.81
Change
+$0.01 (+1.25%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
89.57M
34 days until earnings call
Intraday BUY SELL Signals
SABS
Price
$2.98
Change
-$0.08 (-2.61%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
292.52M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RANI vs SABS

RANI vs SABS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
RANI vs. SABS commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RANI is a Hold and SABS is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
RANISABS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (RANI: $0.80 vs. SABS: $3.06)
Brand notoriety: RANI and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RANI: 55% vs. SABS: 94%
Market capitalization -- RANI: $89.57M vs. SABS: $292.52M
RANI [@Biotechnology] is valued at $89.57M. SABS’s [@Biotechnology] market capitalization is $292.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RANI’s FA Score shows that 1 FA rating(s) are green while SABS’s FA Score has 0 green FA rating(s).

  • RANI’s FA Score: 1 green, 4 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, RANI is a better buy in the long-term than SABS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RANI’s TA Score shows that 3 TA indicator(s) are bullish while SABS’s TA Score has 4 bullish TA indicator(s).

  • RANI’s TA Score: 3 bullish, 6 bearish.
  • SABS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SABS is a better buy in the short-term than RANI.

Price Growth

RANI (@Biotechnology) experienced а +6.21% price change this week, while SABS (@Biotechnology) price change was -8.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.84%. For the same industry, the average monthly price growth was -14.57%, and the average quarterly price growth was -1.99%.

Reported Earning Dates

RANI is expected to report earnings on Nov 05, 2026.

SABS is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-3.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
RANI
Daily Signal:
Gain/Loss:
SABS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SYLD81.120.53
+0.66%
Cambria Shareholder Yield ETF (SYLD)
AESR19.970.09
+0.45%
Anfield U.S. Equity Sector Rotation ETF (AESR)
SPYG123.390.31
+0.25%
State Street SPDR Portfolio S&P 500 Growth ETF (SPYG)
MMAX27.49N/A
+0.01%
iShares Large Cap Max Buffer Mar ETF (MMAX)
NBCE37.02-0.19
-0.50%
Neuberger China Equity ETF (NBCE)

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with ARTV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
+0.57%
ARTV - RANI
47%
Loosely correlated
-4.63%
ARMP - RANI
44%
Loosely correlated
-9.81%
ACHV - RANI
42%
Loosely correlated
-6.92%
IRON - RANI
36%
Loosely correlated
-2.83%
SABS - RANI
34%
Loosely correlated
-3.47%
More

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-3.47%
REVB - SABS
48%
Loosely correlated
-1.96%
INKT - SABS
47%
Loosely correlated
+1.43%
CYPH - SABS
46%
Loosely correlated
-12.31%
TECX - SABS
35%
Loosely correlated
-2.66%
RANI - SABS
34%
Loosely correlated
+0.57%
More